Get started
Author

Patrick Sfumato

Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
2023 · Claire L Vale, David J Fisher, et al. · The Lancet Oncology · 98
PDF
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
2021 · François Bertucci, Anthony Gonçalves, et al. · Genome Medicine · 51
PDF
Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era
2015 · Gwenaelle Gravis, Brice Chanez, et al. · Urologic Oncology Seminars and Original Investigations · 33
Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes
2016 · G. Houvenaeghel, J.M. Boher, et al. · European Journal of Cancer · 28
Defining more precisely the effects of docetaxel plus ADT for men with mHSPC: Meta-analysis of individual participant data from randomized trials.
2022 · Claire Louise Vale, David Fisher, et al. · Journal of Clinical Oncology · 25
Musculoskeletal immune-related adverse events in 927 patients treated with immune checkpoint inhibitors for solid cancer
2022 · Angélique Melia, Emilie Fockens, et al. · Joint Bone Spine · 18
Socioeconomic deprivation is associated with decreased survival in patients with acute myeloid leukemia
2020 · Anne-Charlotte Le Floch, François Eisinger, et al. · Cancer Epidemiology · 17
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
2016 · L Boudin, A Gonçalves, et al. · Bone Marrow Transplantation · 17
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients
2021 · Cecile Vicier, Patrick Sfumato, et al. · European Journal of Cancer · 14
Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy
2021 · Pierre REGNIER, Valeria DE LUCA, et al. · Minerva Urology and Nephrology · 13
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
2019 · Renaud Sabatier, Emmanuelle Charafe-Jauffret, et al. · Journal of Clinical Medicine · 12
PDF
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology
2018 · Bastien Cabarrou, Patrick Sfumato, et al. · European Journal of Cancer · 12
EUS-guided hepaticogastrostomy in the management of malignant biliary obstruction: Experience and learning curve in a tertiary referral center
2022 · Mariola Marx, Fabrice Caillol, et al. · Digestive and Liver Disease · 11
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer
2018 · Pierre Annede, Hugues Mailleux, et al. · Brachytherapy · 11
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial
2022 · Emilien Billon, Gwenaelle Gravis, et al. · Cancers · 9
PDF
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study
2022 · Renaud Sabatier, Cécile Vicier, et al. · Molecular Oncology · 9
PDF
Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial
2017 · P. Marino, P. Sfumato, et al. · European Journal of Cancer · 9
Goftte: A R package for assessing goodness-of-fit in proportional (sub) distributions hazards regression models
2019 · P. Sfumato, T. Filleron, et al. · Computer Methods and Programs in Biomedicine · 8
PDF
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study
2016 · Laurys Boudin, Anthony Gonçalves, et al. · Journal of Cancer · 8
PDF
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC)
2016 · J. E. Cheikh, P. Sfumato, et al. · Haematologica · 7
Autologous Stem Cell Transplant in 2nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience
2022 · Aude Collignon, Benjamin Bouchacourt, et al. · Blood · 6
Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF
2020 · Sylvain Garciaz, Patrick Sfumato, et al. · PLoS ONE · 6
PDF
Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy and post cystectomy complications.
2020 · P. Régnier, De Luca, et al. · Minerva Urologica e Nefrologica · 6
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial
2021 · Renaud Sabatier, Jean-Yves Pierga, et al. · Cancers · 5
PDF
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation
2016 · Laurys Boudin, Christian Chabannon, et al. · European Journal of Cancer · 5
Works count: 59
Citation count: 455
H-index: 12
I10-index: 14
Year
Topic
Type